C

큐리옥스바이오시스템즈

445680KOSDAQ의료용 기기 제조업

43.8 / 100

Reference Date: 2026-07-24

Financial Score12.0 / 40
News Sentiment18.8 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 18.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Curiox Biosystems sells automated equipment and consumables for cell analysis processes, leveraging its decade-long developed Curiox C-FREE™ technology to automate preprocessing steps, significantly improving data accuracy and reproducibility. This technology, based on microfluidics and surface science, is used by pharmaceutical companies and research institutions in the US, Europe, and China. The company has subsidiaries in the US, China, and Singapore to expand its global market presence.

Number of Employees

22people

Average Salary

70.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 20.044.0Point
PBR
12.15Industry Average 1.140.0Point

10.7x industry avg (risky)

ROE
-53.58Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
3.49Industry Average 11.658.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼10.1% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼9.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -30.1% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 37,300Won52-week high 139,60052-week low 34,600
1-month return0.0Point

1m -18.74% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral전환사채(해외전환사채포함)발행후만기전사채취득 (제1회차)2026-06-29